pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 601–700 of 1,003
The role of cyclin E in the regulation of entry into S phase
Sauer, K., & Lehner, C. F. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_10 · Cited by 82
CDKS and CKIS: Molecular targets for tissue remodelling
Nabel, E. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd869 · Cited by 85
Aberrant ubiquitin-mediatedproteolysis of cell cycle regulatory proteins and oncogenesis
Bashir, T., & Pagano, M. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)88305-7 · Cited by 79
Untergasser, G., Gander, R., Rumpold, H. F., Heinrich, E., Plas, E., & Berger, P. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.08.008 · Cited by 78
Bellmunt, J., Ribas, A., Eres, N., Albanell, J., Almanza, C., Bermejo, B., Sol�, L.-A., & Baselga, J. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971115)80:10<1966::aid-cncr14>3.0.co;2-w · Cited by 228
Miyazaki, T., & Arai, S. (2007) · Cell Cycle · doi:10.4161/cc.6.12.4409 · Cited by 71
Pharmacogenetics: from discovery to patient care
Shin, J., Kayser, S. R., & Langaee, T. Y. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080170 · Cited by 74
Musgrove, E. A., Liuschkis, R., Cornish, A. L., Lee, C. S. L., Setlur, V., Seshadri, R., & Sutherland, R. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630420 · Cited by 71
Schmidt, E., Ichimura, K., Messerle, K. R., Goike, H., & Collins, V. P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.2 · Cited by 77
Transforming growth factor β and cancer
Nørgaard, P. H., Hougaard, S., Poulsen, H. S., & Spang‐Thomsen, M. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90038-1 · Cited by 77
CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds
Fargnoli, M. C., Chimenti, S., Peris, K., Keller, G., Soyer, H. P., Pozzo, V. D., & Höfler, H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00412.x · Cited by 80
Tevelev, A., Byeon, I. L., Selby, T. L., Ericson, K. L., Kim, H. J., Kraynov, V. S., & Tsai, M. (1996) · Biochemistry · doi:10.1021/bi960211+ · Cited by 85
MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton, T. A., Samara, G., Chung, W., Yuan, L., Desai, R. D., Sisti, M. B., Bruce, J., & Tycko, B. (1995) · PubMed · Cited by 86
Smad3 phosphorylation by cyclin-dependent kinases
LIU, F. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.010 · Cited by 71
p15INK4b in HDAC inhibitor‐induced growth arrest
Hitomi, T., Matsuzaki, Y., Yokota, T., Takaoka, Y., & Sakai, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01186-4 · Cited by 71
Effects of Progesterone Treatment on Expression of Genes Involved in Uterine Quiescence
Soloff, M. S., Jeng, Y., Izban, M. G., Sinha, M., Luxon, B. A., Stamnes, S. J., & England, S. K. (2011) · Reproductive Sciences · doi:10.1177/1933719111398150 · Cited by 78
“Increased TGF-b signaling likely accounts for the expression of genes associated with cell cycle arrest, a hallmark of TGF-b action.(51,52) Inhibin bB, a member of the TGF-b superfamily, also was upregulated (2.”
BackgroundDifferential regulation of p21 by p53 and Rb in cellular response to oxidative stress
Yin, Y., Solomon, G., Deng, C., & Barrett, J. C. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199901)24:1<15::aid-mc3>3.0.co;2-y · Cited by 71
Alterations of INK4A and INK4B Genes in Adult Soft Tissue Sarcomas: Effect on Survival
Orlow, I., Drobnjak, M., Zhang, Z.-F., Lewis, J., Woodruff, J. M., Brennan, M. F., & Cordon-Cardo, C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.73 · Cited by 71
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2099::aid-cncr8>3.0.co;2-3 · Cited by 2,101
p16INK4A and p15INK4B gene deletions in primary leukemias
Haidar, M., Cao, X., Manshouri, T., Chan, L., Glassman, A., Kantarjian, H., Keating, M., Beran, M., & Albitar, M. (1995) · Blood · doi:10.1182/blood.v86.1.311.bloodjournal861311 · Cited by 71
Molecular cloning and characterization of the human p27Kip1 gene promoter1
Minami, S., Ohtani‐Fujita, N., Igata, E., Tamaki, T., & Sakai, T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00660-1 · Cited by 71
Miller, S. J., Suthiphongchai, T., Zambetti, G. P., & Ewen, M. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8420-8431.2000 · Cited by 78
Tokino, T., Urano, T., Furuhata, T., Matsushima, M., Miyatsu, T., Sasaki, S., & Nakamura, Y. (1996) · Human Genetics · doi:10.1007/bf02281873 · Cited by 77
“…molecular proteins not only bind to the cyclin complexes, but are potent inhibitors of the associated CDKs (p21, Harper et al. 1993; Xiong et al. 1993; Gu et al. 1993; p16, Serrano et al. 1993; p15, Hannon and Beach 1994; p18, Guan et al. 1994; p27, Polyak et al. 1994; Toyoshima and Hunter 1994).”
BackgroundThe Renaissance of Cyclin Dependent Kinase Inhibitors
Ettl, T., Schulz, D., & Bauer, R. J. (2022) · Cancers · doi:10.3390/cancers14020293 · Cited by 76
Ameln, A. K., Muschter, A., Mamlouk, S., Kalucka, J. M., Prade, I., Franke, K., Rezaei, M., Poitz, D. M., Breier, G., & Wielockx, B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3838 · Cited by 76
“TGFβ itself can only induce cell cycle arrest at G1 (26) by activating various antiproliferative responses such as the transcriptional upregulation of CDK inhibitors, like p15, p21 and p27, which specifically requires the downregulation of cMyc (16, 27-29).”
BackgroundBox, A. H., & Demetrick, D. J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh274 · Cited by 81
Inhibin and p27 Interact to Regulate Gonadal Tumorigenesis
Cipriano, S. C., Chen, L., Burns, K. H., Koff, A., & Matzuk, M. M. (2001) · Molecular Endocrinology · doi:10.1210/me.15.6.985 · Cited by 73
Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development
Sakashita, K., Koike, K., Kinoshita, T., Shiohara, M., Kamijo, T., Taniguchi, S., & Kubota, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13030 · Cited by 70
Kato, A., Takahashi, H., Takahashi, Y., & Matsushime, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8065 · Cited by 76
Gong, J., Ammanamanchi, S., Ko, T. C., & Brattain, M. G. (2003) · PubMed · Cited by 73
Worsham, M. J., Chen, K. M., Tiwari, N., Pals, G., Schouten, J. P., Sethi, S. N., & Benninger, M. S. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.4.409 · Cited by 70
Hashimoto, Y., Kohri, K., Kaneko, Y. S., Morisaki, H., Kato, T., Ikeda, K., & Nakanishi, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16544 · Cited by 71
Xia, Y., Liu, Y., Yang, C., Simeone, D. M., Sun, T., DeGraff, D. J., Tang, M.-S., Zhang, Y., & Wu, X. (2021) · Nature Communications · doi:10.1038/s41467-021-22327-5 · Cited by 77
Bockstaele, L., Coulonval, K., Kooken, H., Paternot, S., & Roger, P. P. (2006) · Cell Division · doi:10.1186/1747-1028-1-25 · Cited by 86
Canavese, G., Azzoni, C., Pizzi, S., Corleto, V. D., Pasquali, C., Davoli, C., Crafa, P., Fave, G. D., & Bordi, C. (2001) · Human Pathology · doi:10.1053/hupa.2001.28234 · Cited by 68
Differentiation-Related Changes in the Cell Cycle Traverse
Studzinski, G. P., & Harrison, L. E. (1999) · International review of cytology · doi:10.1016/s0074-7696(08)61384-4 · Cited by 76
Enomoto, K., Mimura, T., Harris, D. L., & Joyce, N. C. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1581 · Cited by 69
Ässämäki, R., Sarlomo‐Rikala, M., López‐Guerrero, J. A., Lasota, J. P., Andersson, L. C., Llombart‐Bosch, A., Miettinen, M., & Knuutila, S. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20439 · Cited by 67
“Together these three tumor suppressors regulate two important cell cycle checkpoints and the loss of these genes can lead to replicative senescence, cell immortalization, and tumor generation (Serrano et al., 1993; Hannon and Beach, 1994; Kamb et al., 1994; Enders, 2003).”
BackgroundBallock, R. T. (2000) · Endocrinology · doi:10.1210/en.141.12.4552 · Cited by 67
CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults—An array CGH study
Usvasalo, A., Savola, S. P., Räty, R., Vettenranta, K. K., Harila‐Saari, A. H., Koistinen, P., Savolainen, E., Elonen, E., Saarinen‐Pihkala, U. M., & Knuutila, S. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.01.014 · Cited by 66
Ried, T., Knutzen, R., Steinbeck, R., Blegen, H., Schröck, E., Heselmeyer, K., du Manoir, S., & Auer, G. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199604)15:4<234::aid-gcc5>3.0.co;2-2 · Cited by 404
Expression of p27Kip1 in Osteoblast-Like Cells during Differentiation with Parathyroid Hormone
Onishi, T., & Hruska, K. A. (1997) · Endocrinology · doi:10.1210/en.138.5.1995 · Cited by 70
Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease
Arendt, T. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00007-7 · Cited by 67
“…cyclin-dependent kinase inhibitor (cdki) family which bind directly to cdk4/6 or to complexes of cdk4/6 with D-type cyclins (Serrano et al., 1993; Hannon and Beach, 1994; Hirai et al., 1995; Biggs and Kraft, 1995; Cordon-Cardo, 1995; Sherr and Roberts, 1995; Boice and Fairman, 1996; Guan et al.,…”
BackgroundTGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki, H., Nishizawa, K., Michaud, G. Y., Cossman, J., & Kiyono, T. (1998) · PubMed · Cited by 67
Chemical inhibitors of cyclin-dependent kinases
Meijer, L. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_29 · Cited by 74
Byun, H.-O., Jung, H.-J., Seo, Y.-H., Lee, Y.-K., Hwang, S.-C., Seong Hwang, E., & Yoon, G. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.012 · Cited by 66
de Miranda, N. F. C. C., van Dinther, M., van den Akker, B. E. W. M., van Wezel, T., ten Dijke, P., & Morreau, H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.052 · Cited by 71
Komata, T., Kanzawa, T., Takeuchi, H., Germano, I. M., Schreiber, M., Kondo, Y., & Kondo, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600862 · Cited by 66
“One class, the inhibitor of CDK4 (INK4) family, which consists of p15INK4B, p16INK4A, p181NK4C and p19INK4D, specifically binds CDK4 or CDK6 and inhibits cyclin D association (Serrano et al, 1993; Guan et al, 1994; Hannon and Beach, 1994; Hirai et al, 1995).”
BackgroundSiegmund, R. F., & Nasmyth, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2647 · Cited by 88
Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro
Soda, H., Raymond, É., Sharma, S., Lawrence, R. A., Davidson, K. K., Oka, M., Kohno, S., Izbicka, E., & Hoff, D. D. V. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000515)43:3<161::aid-pros1>3.0.co;2-o · Cited by 54
Kanzler, S., Meyer, E., Lohse, A. W., Schirmacher, P., Henninger, J., Galle, P. R., & Blessing, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204544 · Cited by 74
Possible association between gastric cancer and bracken fern in Venezuela: An epidemiologic study
Alonso‐Amelot, M. E., & Avendaño, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010115)91:2 · Cited by 66
Glick, A., Popescu, N., Alexander, V., Ueno, H., Bottinger, E., & Yuspa, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14949 · Cited by 66
Shou, W., & Dunphy, W. G. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.457 · Cited by 68
Senescence in chronic wounds and potential targeted therapies
Wei, X., Li, M., Zheng, Z., Ma, J., Gao, Y., Chen, L., Peng, Y., Yu, S., & Yang, L. (2022) · Burns & Trauma · doi:10.1093/burnst/tkab045 · Cited by 73
Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
Hayslip, J. W., & Montero, A. J. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-44 · Cited by 76
Expression of p19 INK4d, CDK4, CDK6 in glioblastoma multiforme
Ng, H. (2000) · British Journal of Neurosurgery · doi:10.1080/02688690042870 · Cited by 65
IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T
Frommer, K., Reichenmiller, K., Schüett, B. S., Hoeflich, A., Ranke, M. B., Dodt, G., & Elmlinger, M. W. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01955 · Cited by 72
“ILK (Li et al. 2003) as well as CDKN2B (p15INK4B) (Hannon & Beach 1994) have been shown to be a part of the pro-apoptotic response of cells exerted by TGF-b, which itself is upregulated by IGFBP-2 stimulation.”
BackgroundA Secreted Tumor-Suppressor, mac25, with Activin-Binding Activity
Kato, M. V. (2000) · Molecular Medicine · doi:10.1007/bf03401780 · Cited by 64
Huang, Y. K., Hutter, D., Liu, Y., Wang, X., Sheikh, M. S., Chan, A. M.-L., & Holbrook, N. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909431199 · Cited by 72
Yoshiji, H., Harris, S. R., Raso, E., Gomez, D. E., Lindsay, C. K., Shibuya, M., Sinha, C. C., & Thorgeirsson, U. P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980105)75:1<81::aid-ijc13>3.0.co;2-g · Cited by 119
Signaling by the transforming growth factor-β receptor
Yingling, J. M., Wang, X., & Bassing, C. H. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00007-2 · Cited by 79
Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells
Anumanthan, G., Halder, S., Osada, H., Takahashi, T., Massion, P. P., Carbone, D. P., & Datta, P. K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602831 · Cited by 64
“In epithelial cells from the skin, lung, and breast, TGF-b rapidly elevates expression of the Cdk4/6 inhibitor p15INK4B (Hannon and Beach, 1994).”
BackgroundMechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer.
Lin, R., & Zhao, L. (2015) · PubMed Central · doi:10.7497/j.issn.2095-3941.2015.0015 · Cited by 118
Stat3-Dependent Induction of p19INK4D by IL-10 Contributes to Inhibition of Macrophage Proliferation
O’Farrell, A.-M., Parry, D. A., Zindy, F., Roussel, M. F., Lees, E., Moore, K. W., & Mui, A. L. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4607 · Cited by 64
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression
Zhang, Z., Rosen, D. G., Yao, J. L., Huang, J., & Liu, J. (2006) · Modern Pathology · doi:10.1038/modpathol.3800655 · Cited by 73
MUTATION OF CELL CYCLE REGULATORS AND THEIR IMPACT ON SUPERFICIAL BLADDER CANCER
Rabbani, F., & Cordon-Cardo, C. (2000) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70237-8 · Cited by 75
Viruses – seeking and destroying the tumor program
O’Shea, C. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209047 · Cited by 73
Protein dephosphorylation and the intracellular control of the cell number
Berndt, N. (1999) · Frontiers in bioscience · doi:10.2741/berndt · Cited by 70
“Hannon, G. J. & D. Beach: p15INK4B is a potential effector of TGF-β-induced cell cycle arrest.”
BackgroundInfluentialKilleen, M. T., Coulombe, B., & Greenblatt, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50111-9 · Cited by 75
Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
Ezhevsky, S. A., Toyoshima, H., Hunter, T. R., & Scott, D. W. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.4.553 · Cited by 65
Warner, D. R., Greene, R. M., & Pisano, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.024 · Cited by 71
Nakanishi, Y., Kamijo, R., Takizawa, K., Hatori, M., & NAGUMO, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00160-5 · Cited by 65
Seo, T., Park, J., & Choe, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2374 · Cited by 63
The p15INK4b/p16INK4a/RB1 Pathway Is Frequently Deregulated in Human Pituitary Adenomas
Ogino, A., Yoshino, A., Katayama, Y., Watanabe, T., Ota, T., Komine, C., Yokoyama, T., & Fukushima, T. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.5.398 · Cited by 63
Wagner, E. F., Hleb, M., Hanna, N. N., & Sharma, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1123 · Cited by 70
Yasui, W., Kuniyasu, H., Yokozaki, H., Semba, S., Tahara, E., & Shimamoto, F. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00196815 · Cited by 67
Cayuela, J., Gardie, B., & Sigaux, F. (1997) · Blood · doi:10.1182/blood.v90.9.3720 · Cited by 72
Ciarallo, S., Subramaniam, V., Hung, W., Lee, J. H., Kotchetkov, R., Sandhu, C., Milic, A., & Slingerland, J. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2993-3002.2002 · Cited by 77
Souza, R. F., Morales, C. P., & Spechler, S. J. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01046.x · Cited by 76
Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma
Koduru, P., Zariwala, M. G., Soni, M., Gong, J., Xiong, Y., & Broome, J. (1995) · Blood · doi:10.1182/blood.v86.8.2900.2900 · Cited by 68
Li, Y., Liu, Y., Chiang, Y. J., Huang, F., Li, Y., Li, X., Ning, Y., Zhang, W., Deng, H., & Chen, Y.-G. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.045 · Cited by 61
Ramsey, M. R., Krishnamurthy, J., Pei, X.-H., Torrice, C., Lin, W., Carrasco, D. R., Ligon, K. L., Xiong, Y., & Sharpless, N. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3437 · Cited by 61
Okamoto, K., Ishida, C., Ikebuchi, Y., Mandai, M., Mimura, K., Murawaki, Y., & Yuasa, I. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3268 · Cited by 69
Agnihotri, S., Wolf, A., Picard, D. J., Hawkins, C. E., & Guha, A. (2009) · Oncogene · doi:10.1038/onc.2009.159 · Cited by 61
“We focused on TGF-b as GATA4 induced p15Ink4b, known to be regulated by TGF-b, including in astrocytes (Hannon and Beach, 1994; Quelle et al., 1995) (Rich et al., 1999).”
Delineating Genetic Pathways of Disease Progression in Head and Neck Squamous Cell Carcinoma
Worsham, M. J., Pals, G., Schouten, J. P., van Spaendonk, R. M. L., Concus, A. P., Carey, T. E., & Benninger, M. S. (2003) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.129.7.702 · Cited by 60
Lambert, K. E., Huang, H., Mythreye, K., & Blobe, G. C. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-11-0877 · Cited by 61
“tors (Elbendary et al., 1994; Hannon and Beach, 1994; Datto et al., 1995; Li et al., 1995; Warner et al., 1999).”
BackgroundTherapeutic effects of histone deacetylase inhibitors on heart disease
Chun, P. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01297-0 · Cited by 63
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Kiyota, A., Shintani, S., Mihara, M., Nakahara, Y., Ueyama, Y., Matsumura, T., Tachikawa, T., & Wong, D. T. (2002) · Oncology · doi:10.1159/000065726 · Cited by 61
Thannickal, V. J., Aldweib, K. D. L., Rajan, T., & Fanburg, B. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9443 · Cited by 73
Sabah, M., Cummins, R., Leader, M., & Kay, E. W. (2004) · Modern Pathology · doi:10.1038/modpathol.3800199 · Cited by 70
TGF-β1 Induces the Cyclin-Dependent Kinase Inhibitor p27 Kip1 mRNA and Protein in Murine B Cells
Kamesaki, H., Nishizawa, K., Michaud, G. Y., Cossman, J., & Kiyono, T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.770 · Cited by 61
Common Variants on Chromosome 9p21 Are Associated with Normal Tension Glaucoma
Takamoto, M., Kaburaki, T., Mabuchi, A., Araie, M., Amano, S., Aihara, M., Tomidokoro, A., Iwase, A., Mabuchi, F., Kashiwagi, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040107 · Cited by 62
Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma
Kudo, Y., Kitajima, S., Ogawa, I., Miyauchi, M., & Takata, T. (2004) · Oral Oncology · doi:10.1016/j.oraloncology.2004.05.003 · Cited by 66
Loar, J. W., Seiser, R. M., Sundberg, A. E., Sagerson, H. J., Ilias-Khan, N. A., Zobel-Thropp, P. A., Craig, E. A., & Lycan, D. E. (2004) · Genetics · doi:10.1534/genetics.104.032656 · Cited by 71
“LY161 was con(Serrano et al. 1993; Hannon and Beach 1994; Chan firmed to be haploid by mating tests. et al. 1995; Hirai et al. 1995; Guan et al. 1996).”
BackgroundPawelec, G. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(94)01549-2 · Cited by 60
浜田, 邦., Kohno, T., Kawanishi, M., Ohwada, S., & Yokota, J. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199807)22:3<232::aid-gcc9>3.0.co;2-x · Cited by 67
Miyazaki, M., Ohashi, R., Tsuji, T., Mihara, K., Gohda, E., & Namba, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8712 · Cited by 59
Sánchez, A., Alvarez, A. M., Benito, M., & Fabregat, I. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650221 · Cited by 64
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.